NEUARTIGE VERBINDUNGEN

Patent europeic · EP2922550 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2922550
Numer da la dumonda
EP13857520
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-11-2013
Publitgà
30-09-2015
Concedì
19-04-2017
Stritgà
30-11-2017
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
Prioritad
US 201261728385 P 20.11.2012
Dumonda PCT
PCT/US2013/070471 18.11.2013
Publicaziun PCT
WO2014/081644 30.05.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-06-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.06.2018

  2. 19-04-2017

    Concedì

    Published in Swissreg on 19.04.2017

Partidas

Possessur

GlaxoSmithKline LLC

Corporation Service Company 2711 Centerville Road Suite 400, Wilmington DE 19808, US

Inventur

COE, Diane Mary

Stevenage Hertfordshire SG1 2NY, GB

SMITH, Stephen Allan

Stevenage Hertfordshire SG1 2NY, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.